Treatment of hypertensive urgency

Key principles

• Rapid BP lowering has no proven benefit. Two large retrospective studies (1016 ED patients and 58,535 outpatients) found very low morbidity and mortality. Prognosis did not differ between patients treated acutely and those discharged with quick follow-up. - Brenner and Rector's The Kidney, p. 2070
• Hospital admission is not needed. In a propensity-matched cohort, patients sent home and patients sent to the ED both had a 0.9% rate of major cardiovascular events at 6 months. - Comprehensive Clinical Nephrology, 7th Ed, p. 546
• The most important step is follow-up. Arrange follow-up, generally within 1 week, at a site that can manage chronic hypertension. Reaching a specific BP target matters less. - Comprehensive Clinical Nephrology, 7th Ed, p. 546

Practical approach

1. Assess for target organ damage. Check the fundi, mental status, and the cardiac, pulmonary and neurologic exams. Do a urinalysis and serum creatinine. Look for clues to secondary hypertension. If you find organ damage, manage it as an emergency.
2. Look for reversible triggers.
   • Treat pain first. Giving fast-acting drugs before analgesia can cause hypotension once the pain resolves.
   • Treat anxiety.
   • Ask about missed doses.
   • Consider withdrawal states (alcohol, cocaine, clonidine, alpha-blockers).
3. Rest in a quiet room.
   • BP fell by at least 20/10 mm Hg in about one-third of patients in an uncontrolled study.
   • A recent RCT found that resting for 2 hours lowered BP as much as telmisartan 40 mg.
   • In many patients BP falls spontaneously within about 30 minutes of quiet rest.
4. Choose between oral therapy and adjusting the long-term regimen.
   • One large observational study found no difference in 1-week ED revisits or BP control between patients who got oral medication in the ED and those who did not.
   • Reasonable strategies are:
     • Restart the usual medications in non-adherent patients.
     • Start a long-acting agent in treatment-naive patients.
     • Intensify therapy in patients who are already treated.
   • If you do treat in the ED, a target of <160/100 mm Hg over 2 to 4 hours is acceptable. This matters most for patients at high short-term risk, such as those with a known aortic aneurysm or recurrent pulmonary edema.
5. Avoid overly rapid lowering. The aim is gradual reduction over hours to days, not minutes.

Oral agents (short-acting options)

Things to avoid

• Immediate-release (sublingual) nifedipine. It can cause precipitous hypotension, stroke, MI and death, and it is now considered contraindicated. The FDA says it "should be used with great caution, if at all."
• Clonidine in non-adherent patients. Do not discharge them on it, because of rebound hypertension.
• Beta-blockers, including labetalol, if pheochromocytoma is suspected. Unopposed alpha stimulation can raise BP. Use an alpha-blocker such as doxazosin or prazosin instead.
• Aggressive treatment of asymptomatic elevation in general. Goldman-Cecil notes that most patients above 180/110 mm Hg do not need immediate oral BP lowering, in the office or the hospital. Its table for oral medications is under "Oral Medications for Hypertensive Urgencies." Goldman-Cecil also states that clonidine shows no discernible clinical benefit for acutely lowering BP in urgency.

Discharge plan

• Start or optimize long-term therapy, ideally with long-acting agents (for example, amlodipine, an ACE inhibitor or ARB, or a thiazide-type diuretic).
• Address adherence, cost and access.
• Recheck BP within about 1 week.

Recent evidence check

• A 2025 review of guidelines on extremely high BP (PMID 41390616).
• A 2024 review of inpatient elevated BP guidelines (PMID 38560900).